105 related articles for article (PubMed ID: 25911942)
1. [Secondary cancers: Incidence, risk factors and recommendations].
Demoor-Goldschmidt C; Fayech C; Girard P; Plantaz D
Bull Cancer; 2015; 102(7-8):656-64. PubMed ID: 25911942
[TBL] [Abstract][Full Text] [Related]
2. Secondary neoplasms following treatment for brain tumors.
Weinstein JL; Ayyanar K; Watral MA
Cancer Treat Res; 2009; 150():239-73. PubMed ID: 19834673
[No Abstract] [Full Text] [Related]
3. Childhood cancer survivor study doubles to examine late effects of new treatments.
Twombly R
J Natl Cancer Inst; 2007 Nov; 99(21):1574-6. PubMed ID: 17971522
[No Abstract] [Full Text] [Related]
4. Solid tumor second primary neoplasms: who is at risk, what can we do?
Oeffinger KC; Baxi SS; Novetsky Friedman D; Moskowitz CS
Semin Oncol; 2013 Dec; 40(6):676-89. PubMed ID: 24331190
[TBL] [Abstract][Full Text] [Related]
5. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
Cohen A; Rovelli A; Merlo DF; van Lint MT; Lanino E; Bresters D; Ceppi M; Bocchini V; Tichelli A; Socié G
J Clin Oncol; 2007 Jun; 25(17):2449-54. PubMed ID: 17557958
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer and other second neoplasms after childhood Hodgkin's disease.
Bhatia S; Robison LL; Oberlin O; Greenberg M; Bunin G; Fossati-Bellani F; Meadows AT
N Engl J Med; 1996 Mar; 334(12):745-51. PubMed ID: 8592547
[TBL] [Abstract][Full Text] [Related]
7. Thyroid adenomas after solid cancer in childhood.
Haddy N; El-Fayech C; Guibout C; Adjadj E; Thomas-Teinturier C; Oberlin O; Veres C; Pacquement H; Jackson A; Munzer M; N'Guyen TD; Bondiau PY; Berchery D; Laprie A; Bridier A; Lefkopoulos D; Schlumberger M; Rubino C; Diallo I; de Vathaire F
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e209-15. PubMed ID: 22672756
[TBL] [Abstract][Full Text] [Related]
8. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
[TBL] [Abstract][Full Text] [Related]
9. Genetic implications of bilateral breast cancer: a population based cohort study.
Hartman M; Czene K; Reilly M; Bergh J; Lagiou P; Trichopoulos D; Adami HO; Hall P
Lancet Oncol; 2005 Jun; 6(6):377-82. PubMed ID: 15925815
[TBL] [Abstract][Full Text] [Related]
10. Pattern of second primary malignancies in thyroid cancer patients.
Okere PC; Olusina DB; Shamim SA; Shandra V; Tushar M; Sellam K; Bal C
Niger J Clin Pract; 2013; 16(1):96-9. PubMed ID: 23377480
[TBL] [Abstract][Full Text] [Related]
11. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
[TBL] [Abstract][Full Text] [Related]
12. [Breast cancer after radiotherapy: Risk factors and suggestion for breast delineation as an organ at risk in the prepuberal girl].
Demoor-Goldschmidt C; Supiot S; Mahé MA
Cancer Radiother; 2012 Apr; 16(2):140-51. PubMed ID: 22342367
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology of second primary cancers.
Travis LB
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2020-6. PubMed ID: 17057028
[TBL] [Abstract][Full Text] [Related]
14. [Secondary neoplasms in 5-year survivors of cancer in childhood: results of the Childhood Cancer Survivor Study].
Beck JD
Strahlenther Onkol; 2002 Mar; 178(3):167-8. PubMed ID: 11962196
[No Abstract] [Full Text] [Related]
15. Secondary malignant neoplasms after childhood cancer.
Varan A; Kebudi R
Pediatr Hematol Oncol; 2011 Aug; 28(5):345-53. PubMed ID: 21413830
[TBL] [Abstract][Full Text] [Related]
16. A French national breast and thyroid cancer screening programme for survivors of childhood, adolescent and young adult (CAYA) cancers - DeNaCaPST programme.
Demoor-Goldschmidt C; Drui D; Doutriaux I; Michel G; Auquier P; Dumas A; Berger C; Bernier V; Bohrer S; Bondiau PY; Filhon B; Fresneau B; Freycon C; Stefan D; Helfre S; Jackson A; Kerr C; Laprie A; Leseur J; Mahé MA; Oudot C; Pluchard C; Proust S; Sudour-Bonnange H; Vigneron C; Lassau N; Schlumberger M; Conter CF; de Vathaire F
BMC Cancer; 2017 May; 17(1):326. PubMed ID: 28499444
[TBL] [Abstract][Full Text] [Related]
17. Second malignant neoplasms following treatment for primary cancer.
Somerville HM
Aust Fam Physician; 2003; 32(1-2):25-31. PubMed ID: 12647655
[TBL] [Abstract][Full Text] [Related]
18. An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors.
Peterson KM; Shao C; McCarter R; MacDonald TJ; Byrne J
Pediatr Blood Cancer; 2006 Jul; 47(1):83-8. PubMed ID: 16317732
[TBL] [Abstract][Full Text] [Related]
19. Design and analysis of epidemiological studies of excess cancer among children exposed to Chernobyl radionuclides.
Peterson LE; Dreyer ZE; Plon SE; Smith JL; Weinberg AD; McCarthy PL
Stem Cells; 1997; 15 Suppl 2():211-30. PubMed ID: 9368307
[TBL] [Abstract][Full Text] [Related]
20. Thyroid cancer as second primary malignancy in breast cancer patients.
Sioka C; Fotopoulos A
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1604; author reply 1604. PubMed ID: 19306760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
